Learn More:
About the Genetics Policy Institute

Home > About GPI

The Genetics Policy Institute (GPI) is a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. We are the catalyst and provide leadership to the Pro-Cures Movement, an influential global network of stakeholders' from patient-advocacy, science and industry.

GPI seeks to catalyze and help lead a global network of influential stakeholder groups representing patient advocates, scientists, physicians and health care professionals, industrialists, bioethicists, lawyers, educators, and policy-makers.

GPI pursues this mission through co-sponsorship and management of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects, speaking engagements, teaching initiatives, and strategic collaborations.

Upon this base of activities and relationships, GPI serves as a communications channel, helping to build the knowledge base needed for ethical and thoughtful policy-making in support of scientifically and medically worthy research and clinical translation in the broad field of stem cells and the even broader field of developmental biology.

The Voice of the Stem Cell Community

GPI is often called upon to provide interviews and expert commentary to the press. GPI's lectures have been quoted in major newspapers and magazines throughout the U.S. and the world, and have been featured on numerous radio and television broadcasts. We create positive public awareness for stem cell research and regenerative medicine.

Executing Our Mission

Through GPI's action network, world report, flagship conference, special projects, speaking engagements, world renowned advisory boards, educational resources, teaching initiatives and strategic relationships, GPI serves as the foremost channel of knowledge between the world leading stem cell experts, patient advocates and those who make policy for the general public.

GPI maintains science and legal advisory boards comprised of leading stem cell researchers, disease experts, ethicists and legal experts and a dedicated fulltime staff of policy, business, science and communication experts that are available to educate the public and media on stem cell issues.

Share:

News & Updates

See All

Upcoming Appearances

See All